Inhibition of Complement Activation (Eculizumab) in Guillain-Barre Syndrome Study
Clinical trial NCT02029378 · UNKNOWN
Trial details
- NCT number
- NCT02029378
- Sponsor
- NHS Greater Glasgow and Clyde
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2015-10-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.